Business
Announcement on Receiving Proposals from the Chairman and One of the Actual Controllers to Implement the 2024 Interim Dividend and the "Corporate Value and Return Enhancement" Action Plan
Announcement on Receiving Proposals from the Chairman and One of the Actual Controllers to Implement the 2024 Interim Dividend and the "Corporate Value and Return Enhancement" Action Plan

About this update from Shanghai Serum Bio-technology Co., Ltd. Class A
Announcement on Receiving Proposals from the Chairman and One of the Actual Controllers to Implement the 2024 Interim Dividend and the "Corporate Value and Return Enhancement" Action Plan The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment
View stock analysis, news, and events for Shanghai Serum Bio-technology Co., Ltd. Class A